New tentative approval for Alembic drug dabigatran etexilate mesylate
Drug Patent Watch
JUNE 30, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Let's personalize your content